Audit 32489

FY End
2022-12-31
Total Expended
$4.30M
Findings
2
Programs
5
Year: 2022 Accepted: 2023-09-28
Auditor: Kpmg INC

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
33729 2022-001 Significant Deficiency - L
610171 2022-001 Significant Deficiency - L

Programs

ALN Program Spent Major Findings
93.395 Cancer Treatment Research $139,150 - 0
93.498 Provider Relief Fund $98,070 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $52,712 - 0
93.575 Child Care and Development Block Grant $16,690 - 0
93.991 Preventive Health and Health Services Block Grant $13,500 - 0

Contacts

Name Title Type
QBNXK4A795N7 Mindy Stetson Auditee
4029556765 Erin Tracy Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The accompanying schedule of expenditures of federal awards includes the federal grant activity of the Hospital and is presented on the accrual basis of accounting. The expenditures reported on the Schedule for Provider Relief Fund, CFDA #93.498, were based on reporting time periods required for PRF portal reporting. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.

Finding Details

(3) Findings and Questioned Costs relating to Federal Awards Finding 2022-011 Compliance Requirement: Reporting Federal Agency: U.S. Department of Health and Human Services Federal Program: Covid-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution - AL No. 93.498 ALN Number: 93.498 Award Year: January 1, 2021 - December 31, 2021 Criteria: The reporting requirements for American Rescue Plan Act (ARPA) state that ARPA payments applied to expenditures should be reported by calendar year quarterly periods within the period of performance. Condition: The Period 4 report submission applied $1,700,047 of ARPA distributions to expenditures, all of which were reported as expenditures incurred during Q1 2022. However, all of these expenditures were incurred in quarters Q1 2020 through Q4 2020. Cause: The Hospital interpreted Provider Relief Fund (PRF) reporting requirements in such a way that ARPA payments applied to expenditures did not need to be classified and reported by the quarterly period incurred. Effect: The Period 4 report submission reported $1,700,047 of ARPA payments as Q1 2022 expenses when all of the payments should have been reported in the Period 4 report in previous quarters. No findings were identified over the period of performance. Identification of Questioned Costs: None Repeat finding: Finding 2022-011 is not a repeat finding Recommendation: We recommend that the Hospital strengthen their system of internal controls around the review of HRSA guidance to ensure that all reporting is consistent with requirements and instructions as provided by regulatory agencies. View of Responsible Officials: Management agrees with the finding. Although reported in the incorrect quarter, the Hospital did incur expenses in excess of the amount of ARPA funds received. In addition, the Hospital also suffered lost revenues in excess of the ARPA funds received. Management will refine its review process of HRSA guidance and data entry into the portal to ensure appropriate designation between reporting periods.
(3) Findings and Questioned Costs relating to Federal Awards Finding 2022-011 Compliance Requirement: Reporting Federal Agency: U.S. Department of Health and Human Services Federal Program: Covid-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution - AL No. 93.498 ALN Number: 93.498 Award Year: January 1, 2021 - December 31, 2021 Criteria: The reporting requirements for American Rescue Plan Act (ARPA) state that ARPA payments applied to expenditures should be reported by calendar year quarterly periods within the period of performance. Condition: The Period 4 report submission applied $1,700,047 of ARPA distributions to expenditures, all of which were reported as expenditures incurred during Q1 2022. However, all of these expenditures were incurred in quarters Q1 2020 through Q4 2020. Cause: The Hospital interpreted Provider Relief Fund (PRF) reporting requirements in such a way that ARPA payments applied to expenditures did not need to be classified and reported by the quarterly period incurred. Effect: The Period 4 report submission reported $1,700,047 of ARPA payments as Q1 2022 expenses when all of the payments should have been reported in the Period 4 report in previous quarters. No findings were identified over the period of performance. Identification of Questioned Costs: None Repeat finding: Finding 2022-011 is not a repeat finding Recommendation: We recommend that the Hospital strengthen their system of internal controls around the review of HRSA guidance to ensure that all reporting is consistent with requirements and instructions as provided by regulatory agencies. View of Responsible Officials: Management agrees with the finding. Although reported in the incorrect quarter, the Hospital did incur expenses in excess of the amount of ARPA funds received. In addition, the Hospital also suffered lost revenues in excess of the ARPA funds received. Management will refine its review process of HRSA guidance and data entry into the portal to ensure appropriate designation between reporting periods.